News
11-17-2011, 04:16 AM
About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report side effects such as weight gain and sexual dysfunction, which prompts more than 20 percent of them to discontinue treatment, according to researchers at The University of Texas MD Anderson Cancer Center...
More... (http://www.medicalnewstoday.com/releases/237814.php)
More... (http://www.medicalnewstoday.com/releases/237814.php)